Rubicon Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rubicon Advisors's LLY Position: Q3 2026 in Review
Rubicon Advisors held its Eli Lilly (LLY) position steady in Q3 2026 at 489 shares worth $565K. The position accounts for 0.39% of the portfolio, ranked #55.
Rubicon Advisors first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $586K in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Rubicon Advisors held 489 shares of Eli Lilly worth $565K as of Q3 2026.
- Rubicon Advisors left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.39% of Rubicon Advisors's portfolio in Q3 2026, its #55 holding.
- Rubicon Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- Rubicon Advisors's Eli Lilly position peaked at $586K in Q2 2026.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Rubicon Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.